test 7 insulin and insulin analogues Flashcards
1
Q
Basic facts on insulin
A
- Insulin is a polypeptide, consisting of 2 chains and connecting peptide (c-peptide). Referred to proinsulin.
- Proteases cleave the c-peptide from the A and B chains, producing insulin and c-peptide, and both are contained in secretory granules prior to release.
- Insulin undergoes significant hepatic degradation during its “first pass”. Hence, the half life of insulin is short and under 6 minutes. The half live of c-peptide is ~ 30 minutes.
- Thus, plasma insulin levels do not accurately reflect insulin production. C-peptide is a better index.
2
Q
Insulin preparations are categorized by their
A
- onset and duration of activity.
3
Q
how is insulin administered
A
- Insulin is generally administered by subcutaneous injections. Insulin may be given by an intravenous infusion in case of hyperglycemic conditions.
- Continuous subcutaneous infusion infusions (insulin pump) is another method of delivery.
4
Q
Rapid onset and short-acting insulin
A
- Modification of regular insulin produces fast-acting analogues with rapid absorption, quicker action, and shorter duration.
- Administered to mimic mealtime insulin levels and control for postprandial blood glucose.
5
Q
Intermediate-acting insulin
A
- Neutral protamine Hagedorn (NPH) is intermediate acting by the addition of zinc and protamine to regular insulin. (Humulin N, Novolin N)
- This complex is less soluble, delaying the absorption, resulting in a longer duration of action. Only given by SC.
6
Q
Long-acting insulin
A
- Long-acting insulin contain a fatty acid chain that binds to albumin. Slow dissociation from albumin results in long-lasting effects.
- Should only be given SC and not mixed with other types of insulin.
7
Q
Insulin combinations
A
• Premixed combinations such as NPH and regular insulin can be used. This cocktail decreases the number of daily injections.
8
Q
Importance of tight blood glucose regulation
A
- Risk of cardiovascular disease and neuropathies is enhanced in the diabetic patient and the incidence of diabetics undergoing CABG is increased.
- Severity (and complications) of cardiovascular complications is also increased by the diabetic state.
- Mortality rates after CAGB is also higher in diabetes.
- Aggressive treatment, although associated with increased frequency of hypoglycemia, this reduces the incidence of long-term complications
9
Q
The ADA recommends blood glucose levels
A
- below 150 mg/dl or glycated hemoglobin (HBA1c, a form of Hb) under 7% (normal is below 5.7%).
- HBA1c identifies 3 month average blood glucose control. As the average amount of plasma glucose in the blood increases, the fraction of glycated hemoglobin increases.
- With diabetes, as expected, both glucose levels and fluctuation of, increase thus resulting in higher HBA1c percentages.